These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 5571501

  • 41. [New biochemical variants of oxalosis and renued clinical interest in such diathesis].
    G Clin Med; 1969 Jun; 50(6):461-3. PubMed ID: 5386606
    [No Abstract] [Full Text] [Related]

  • 42. Three kidney transplantations in a patient with primary hereditary hyperoxaluria.
    Koch B, Irvine AH, Barr JR, Poznanski WJ.
    Can Med Assoc J; 1972 Jun 24; 106(12):1323 passim. PubMed ID: 4556239
    [No Abstract] [Full Text] [Related]

  • 43. The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre.
    Clifford-Mobley O, Tims C, Rumsby G.
    Ann Clin Biochem; 2015 Jan 24; 52(Pt 1):113-21. PubMed ID: 24719216
    [Abstract] [Full Text] [Related]

  • 44. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.
    Hoppe B, Groothoff JW, Hulton SA, Cochat P, Niaudet P, Kemper MJ, Deschênes G, Unwin R, Milliner D.
    Nephrol Dial Transplant; 2011 Nov 24; 26(11):3609-15. PubMed ID: 21460356
    [Abstract] [Full Text] [Related]

  • 45. [Metabolic nephropathy with oxalate-calcium crystalluria in children].
    Baĭgil'dina LM.
    Med Sestra; 1985 Apr 24; 44(4):35-8. PubMed ID: 3847741
    [No Abstract] [Full Text] [Related]

  • 46. Indirect estimation of plasma oxalate using 14C-oxalate.
    Prenen JA, Oei HY, Dorhout Mees EJ.
    Contrib Nephrol; 1987 Apr 24; 56():18-25. PubMed ID: 3608491
    [No Abstract] [Full Text] [Related]

  • 47. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1.
    Hoppe B, Beck B, Gatter N, von Unruh G, Tischer A, Hesse A, Laube N, Kaul P, Sidhu H.
    Kidney Int; 2006 Oct 24; 70(7):1305-11. PubMed ID: 16850020
    [Abstract] [Full Text] [Related]

  • 48. [Severe renal failure in a child].
    Maringhini S, D'Alessandro MM, Di Martino A, Stella M, Raiata F, Marangella M.
    G Ital Nefrol; 2004 Oct 24; 21(6):581-6. PubMed ID: 15593027
    [Abstract] [Full Text] [Related]

  • 49. Urolithiasis and hyperoxaluria in chronic inflammatory bowel disease.
    Hylander E, Jarnum S, Frandsen I.
    Scand J Gastroenterol; 1979 Oct 24; 14(4):475-9. PubMed ID: 482860
    [Abstract] [Full Text] [Related]

  • 50. Oxalate dynamics in chronic renal failure. Comparison with normal subjects and patients with primary hyperoxaluria.
    Morgan SH, Purkiss P, Watts RW, Mansell MA.
    Nephron; 1987 Oct 24; 46(3):253-7. PubMed ID: 3306417
    [Abstract] [Full Text] [Related]

  • 51. Prolonged survival after renal transplantation in primary hyperoxaluria of childhood.
    Leumann EP, Wegmann W, Largiadèr F.
    Clin Nephrol; 1978 Jan 24; 9(1):29-34. PubMed ID: 343953
    [Abstract] [Full Text] [Related]

  • 52. The identification of the enzymes that catalyse the oxidation of glyoxylate to oxalate in the 100000 g supernatant fraction of human hyperoxaluric and control liver and heart tissue.
    Gibbs DA, Watts RW.
    Clin Sci; 1973 Mar 24; 44(3):227-41. PubMed ID: 4348266
    [No Abstract] [Full Text] [Related]

  • 53. Combined liver-kidney transplantation in primary hyperoxaluria type 1. Bone histopathology and oxalate body content.
    Toussaint C, Vienne A, De Pauw L, Gelin M, Janssen F, Hall M, Schurmans T, Pasteels JL.
    Transplantation; 1995 Jun 27; 59(12):1700-4. PubMed ID: 7604440
    [Abstract] [Full Text] [Related]

  • 54. [Hyperoxaluria and renal calculi].
    Buño Soto A, Torres Jiménez R, García Puig J, Mateos Antón F.
    Arch Esp Urol; 1996 Sep 27; 49(7):707-26. PubMed ID: 9020008
    [Abstract] [Full Text] [Related]

  • 55. Long-term survival of a renal allograft in a patient with primary hyperoxaluria (type I).
    Rosier JG, Baadenhuijsen H, Koene RA.
    Neth J Med; 1981 Sep 27; 24(5):179-84. PubMed ID: 7029316
    [No Abstract] [Full Text] [Related]

  • 56. Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1.
    Ruder H, Otto G, Schutgens RB, Querfeld U, Wanders RJ, Herzog KH, Wölfel P, Pomer S, Schärer K, Rose GA.
    Eur J Pediatr; 1990 Nov 27; 150(1):56-8. PubMed ID: 2079078
    [Abstract] [Full Text] [Related]

  • 57. Pyridoxamine lowers oxalate excretion and kidney crystals in experimental hyperoxaluria: a potential therapy for primary hyperoxaluria.
    Scheinman JI, Voziyan PA, Belmont JM, Chetyrkin SV, Kim D, Hudson BG.
    Urol Res; 2005 Nov 27; 33(5):368-71. PubMed ID: 16292584
    [Abstract] [Full Text] [Related]

  • 58. Recurrence of oxalate deposition in a renal transplant during ciclosporin A therapy.
    Drachman R, Dollberg L, Drukker A.
    Child Nephrol Urol; 2005 Nov 27; 9(1-2):90-2. PubMed ID: 3075154
    [Abstract] [Full Text] [Related]

  • 59. Progressive peripheral neuropathy in patient with primary hyperoxaluria.
    Moorhead PJ, Cooper DJ, Timperley WR.
    Br Med J; 1975 May 10; 2(5966):312-3. PubMed ID: 48397
    [Abstract] [Full Text] [Related]

  • 60. Response to a physiologic dose of pyridoxine in type I primary hyperoxaluria.
    Yendt ER, Cohanim M.
    N Engl J Med; 1985 Apr 11; 312(15):953-7. PubMed ID: 3974685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.